Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer who have poor performance status

被引：0

作者：

Kimura, Madoka ^{[1
]}

Nishino, Kazumi ^{[1
]}

Imamura, Fumio ^{[1
]}

Nakashima, Kazuhisa ^{[2
]}

Takahashi, Toshiaki ^{[2
]}

Sugimoto, Takeya ^{[3
]}

Akamatsu, Hiroaki ^{[3
]}

Yamamoto, Nobuyuki ^{[3
]}

Daga, Haruko ^{[4
]}

Imai, Hisao ^{[5
]}

Taira, Tetsuhiko ^{[6
]}

Miyashita, Yosuke ^{[7
]}

Ko, Ryo ^{[7
]}

Hisamatsu, Yasushi ^{[8
]}

Murakami, Haruyasu ^{[2
]}

机构：

[1] Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan

[2] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka, Japan

[3] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan

[4] Osaka City Gen Hosp, Dept Med Oncol, Osaka, Japan

[5] Gunma Prefectural Canc Ctr, Div Resp Med, Ota, Japan

[6] Minami Kyushu Natl Hosp, Div Pulm Med, Aira, Kagoshima, Japan

[7] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan

[8] Oita Prefectural Hosp, Dept Thorac Med Oncol, Oita, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O2 - 11 -

引用

页数：1

共 50 条

[1] Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer and a poor performance status
Nakashima, Kazuhisa
Kimura, Madoka
Akamatsu, Hiroaki
Daga, Haruko
Imai, Hisao
Taira, Tetsuhiko
Ko, Ryo
Hisamatsu, Yasushi
Nishino, Kazumi
Sugimoto, Takeya
Miyashita, Yosuke
Takahashi, Toshiaki
Kumagai, Toru
Yamamoto, Nobuyuki
Murakami, Haruyasu
[J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (07) : 671 - 675
[2] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
Soejima, Kenzo
Yasuda, Hiroyuki
Hirano, Toshiyuki
[J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
[3] Real-world osimertinib for EGFR mutation-positive non-small-cell lung cancer with acquired T790M mutation
Imamura, Fumio
Kimura, Madoka
Yano, Yukihiro
Mori, Masahide
Suzuki, Hidekazu
Hirashima, Tomonori
Ihara, Shouichi
Komuta, Kiyoshi
Shiroyama, Takayuki
Nagatomo, Izumi
Kumagai, Toru
[J]. FUTURE ONCOLOGY, 2020, 16 (21) : 1537 - 1546
[4] Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
Kazuhisa Nakashima
Yuichi Ozawa
Haruko Daga
Hisao Imai
Motohiro Tamiya
Takaaki Tokito
Takahisa Kawamura
Hiroaki Akamatsu
Yuko Tsuboguchi
Toshiaki Takahashi
Nobuyuki Yamamoto
Keita Mori
Haruyasu Murakami
[J]. Investigational New Drugs, 2020, 38 : 1854 - 1861
[5] Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
Nakashima, Kazuhisa
Ozawa, Yuichi
Daga, Haruko
Imai, Hisao
Tamiya, Motohiro
Tokito, Takaaki
Kawamura, Takahisa
Akamatsu, Hiroaki
Tsuboguchi, Yuko
Takahashi, Toshiaki
Yamamoto, Nobuyuki
Mori, Keita
Murakami, Haruyasu
[J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (06) : 1854 - 1861
[6] Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
Skoulidis, Ferdinandos
Papadimitrakopoulou, Vassiliki A.
[J]. CLINICAL CANCER RESEARCH, 2017, 23 (03) : 618 - 622
[7] Osimertinib for the Treatment of Metastatic EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
Khozin, Sean
Weinstock, Chana
Blumenthal, Gideon M.
Cheng, Joyce
He, Kun
Zhuang, Luning
Zhao, Hong
Charlab, Rosane
Fan, Ingrid
Keegan, Patricia
Pazdur, Richard
[J]. CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2131 - 2135
[8] Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial
Akamatsu, Hiroaki
Katakami, Nobuyuki
Okamoto, Isamu
Kato, Terufumi
Kim, Young Hak
Imamura, Fumio
Shinkai, Masaharu
Hodge, Rachel A.
Uchida, Hirohiko
Hida, Toyoaki
[J]. CANCER SCIENCE, 2018, 109 (06): : 1930 - 1938
[9] The safety and efficacy of osimertinib for the treatment of EGFR T790M mutation positive non-small-cell lung cancer
Gao, Xin
Le, Xiuning
Costa, Daniel B.
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (04) : 383 - 390
[10] Practical use of osimertinib in Japanese patients with EGFR T790M mutation positive advanced non-small-cell lung cancer
Kotake, M.
Murakami, H.
Naito, T.
Takahashi, T.
Kenmotsu, H.
Ono, A.
Wakuda, K.
Nakashima, K.
Omori, S.
[J]. ANNALS OF ONCOLOGY, 2016, 27

← 1 2 3 4 5 →